Cargando…

Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial

A definitive conclusion regarding the value of low-dose extended duration adjuvant interferon-alpha therapy in the treatment of malignant melanoma is only possible once data on health-related quality of life (HRQoL) and costs have been considered. This trial randomised 674 patients to interferon alp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixon, S, Walters, S J, Turner, L, Hancock, B W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361187/ https://www.ncbi.nlm.nih.gov/pubmed/16449995 http://dx.doi.org/10.1038/sj.bjc.6602973

Ejemplares similares

Interferon Alpha Association with Neuromyelitis Optica
por: Asgari, Nasrin, et al.
Publicado: (2013)

Health-related quality of life and distress in cancer patients: results from a large randomised study
por: Johansson, B, et al.
Publicado: (2008)

Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α
por: Yang, S, et al.
Publicado: (2010)

Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
por: Atzpodien, J, et al.
Publicado: (2005)

Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.
por: Håkansson, A., et al.
Publicado: (1996)

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases – results and lessons learnt
por: Gupta, Avinash, et al.
Publicado: (2016)

Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: final results and geographical analysis
por: Cella, D, et al.
Publicado: (2010)

Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α
por: Kornmann, M, et al.
Publicado: (2010)

Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer
por: Klinkhammer-Schalke, M, et al.
Publicado: (2012)

The Quality of Life of a Multidiagnosis Group of Special Needs Children: Associations and Costs
por: Thurston, Sandy, et al.
Publicado: (2010)

Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial
por: Wu, C-W, et al.
Publicado: (2008)

Second primary malignancies after treatment for malignant lymphoma
por: Okines, A, et al.
Publicado: (2005)

Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens
por: Chiarion-Sileni, V, et al.
Publicado: (2011)

Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma
por: García-Ortega, María Belén, et al.
Publicado: (2023)

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation
por: Fallowfield, L J, et al.
Publicado: (2012)

Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir
por: Tamai, Hideyuki, et al.
Publicado: (2017)

Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study
por: Cameron, D A, et al.
Publicado: (2001)

Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
por: Dhaliwal, Inderdeep, et al.
Publicado: (2016)

Bilateral Single-Port Sympathectomy: Long-Term Results and Quality of Life
por: Ibrahim, Mohsen, et al.
Publicado: (2013)

Health-Care Delay in Malignant Melanoma: Various Pathways to Diagnosis and Treatment
por: Hajdarevic, Senada, et al.
Publicado: (2014)

Interferon Alpha on Expression of hTERT mRNA in Peripheral Blood Mononuclear Cells of Patients with Chronic Hepatitis B
por: Zhu, Chuan-wu, et al.
Publicado: (2011)

The Cooling Effect on Proinflammatory Cytokines Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Nitric Oxide in Patients with Multiple Sclerosis
por: Poyraz, Turan, et al.
Publicado: (2013)

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis
por: Eisen, T, et al.
Publicado: (2006)

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study
por: Mouriaux, F, et al.
Publicado: (2016)

Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab
por: Rogiers, Anne, et al.
Publicado: (2020)

Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
por: Drazilova, Sylvia, et al.
Publicado: (2016)

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
por: Atzpodien, J, et al.
Publicado: (2007)

Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
por: Sivan, Sapoznik, et al.
Publicado: (2012)

Potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer—Results from Phase I Clinical Trials
por: Tanaka, Toshiaki, et al.
Publicado: (2013)

Patient satisfaction with GP-led melanoma follow-up: a randomised controlled trial
por: Murchie, P, et al.
Publicado: (2010)

The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma
por: Wilkins, Anna, et al.
Publicado: (2015)

The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
por: de Kok, I M C M, et al.
Publicado: (2009)

Association of Interferon-Alpha and Ribavirin-Induced Thyroid Dysfunction with Severity of Disease and Response to Treatment in Pakistani Asian Patients of Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2012)

The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial
por: Arnold, D T, et al.
Publicado: (2015)

Increasing the Efficacy of SLNB in Cases of Malignant Melanoma Located in Close Proximity to the Lymphatic Basin
por: Bogdanov-Berezovsky, Alexander, et al.
Publicado: (2014)

Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis
por: Surov, Alexey, et al.
Publicado: (2022)

Dabrafenib in metastatic melanoma: a monocentric ‘real life’ experience
por: Cocorocchio, E, et al.
Publicado: (2016)

Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex
por: Abolfazli, R., et al.
Publicado: (2012)

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma
por: Daud, Adil, et al.
Publicado: (2017)

The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma
por: Suarez, Lorena P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6vmrkbj17g68vd3qjgrn13s653